🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this clinical study is to determine the efficacy and safety ...
Status
Recruiting
Location
Arizona Neuroscience Research, LLC
Start Date
2024-06-25
Trial ID
NCT06463587
Treatments Being Tested
Study and Dose Rationale The safety profile of clofarabine appears acceptab...
Status
Terminated
Location
Huntsman Cancer Institute
Start Date
2008-03
Trial ID
NCT00708721
Treatments Being Tested
The purpose of this study is to compare the effectiveness of two multi-agen...
Status
Completed
Location
Stanford University Medical Center
Start Date
2002-08
Trial ID
NCT00136084
This is a multicenter, randomized, open-label, pragmatic low intervention c...
Status
Recruiting
Location
University Hospital Brno
Start Date
2025-02-27
Trial ID
NCT06713837
Treatments Being Tested
This phase II, open-label, randomized trial will compare the efficacy of th...
Status
Withdrawn
Location
University of Florida
Start Date
2025-04
Trial ID
NCT05766514
Treatments Being Tested
Phase III, multicenter, randomized study with two arms (1:1 ratio) enrollin...
Status
Terminated
Location
O'Neal Comprehensive Cancer Center
Start Date
2019-11-22
Trial ID
NCT03926624
The AML18 Trial will evaluate several relevant therapeutic questions in Acu...
Status
Unknown
Location
Aalborg University Hospital
Start Date
2014-10-30
Trial ID
NCT02272478
This randomized pilot trial studies how well higher or lower dose cladribin...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2016-12-30
Trial ID
NCT03012672
This phase I trial studies the side effects and best dose of a chemotherapy...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2020-05-08
Trial ID
NCT04196010
Treatments Being Tested
To learn if the combination of cladribine, cytarabine, venetoclax, and azac...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2022-09-23
Trial ID
NCT05365035
Treatments Being Tested